News for Healthier Living

Dana-Farber Presents Phase 3 Lung Cancer Data in ESMO Presidential Symposium

Dana-Farber Cancer Institute researchers will present findings at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain. The studies, including a lung cancer clinical trial featured in the Presidential Symposium, will be presented both in-person and online from October 23 to October 27. Additional studies with compelling results span multiple cancer types, including prostate, breast, and kidney.

October 20, 2026


October 20 2026

October 19 2026

October 18 2026

October 17 2026

October 16 2026

October 15 2026

October 14 2026

October 13 2026

October 12 2026

October 11 2026

October 10 2026

October 9 2026

October 8 2026

October 7 2026